# NBL1

## Overview
NBL1, also known as the Neuroblastoma suppressor of tumorigenicity 1, is a gene that encodes a protein belonging to the DAN family of bone morphogenetic protein (BMP) antagonists. The NBL1 protein is characterized by its cystine knot motif and functions primarily as an extracellular antagonist to BMPs, particularly BMP2 and BMP4, by forming noncovalent homodimers that inhibit BMP signaling pathways. This inhibition is crucial for regulating various biological processes, including development, differentiation, and tissue homeostasis. NBL1's role extends to influencing wound healing, interacting with other signaling pathways such as Wnt and VEGF, and modulating cellular processes in diseases like diabetic kidney disease and pulmonary arterial hypertension (Nolan2014The; Tsai2023NBL1; Hung2012DAN). The protein's structural stability and functional interactions underscore its significance in both physiological and pathological contexts.

## Structure
NBL1, also known as DAN, is a member of the DAN family of BMP antagonists. The protein is characterized by a cystine knot motif, which is a common feature among TGF-β superfamily ligands and their antagonists (Nolan2014The). NBL1 contains 10 cysteine residues, which is unique among its family members, and these cysteines are involved in forming a stable noncovalent homodimer (Nolan2014The; Hung2012DAN). The dimerization of NBL1 is not dependent on disulfide bonds, as the odd cysteines remain in a free-sulfhydryl state, preventing disulfide-linked oligomer formation (Nolan2014The).

The protein's structure is stabilized by non-covalent interactions, and it forms a zipper-like antiparallel β-sheet dimerization similar to PRDC, another DAN family member (Nolan2014The). NBL1 is glycosylated, which does not affect its BMP antagonizing function, indicating that glycosylation may play a role in its stability or secretion (Hung2012DAN). The protein's ability to form stable dimers under denaturing conditions suggests a robust tertiary and quaternary structure (Kattamuri2012Members). These structural features are crucial for its function as a BMP antagonist, specifically targeting BMP2 and BMP4 (Hung2012DAN).

## Function
NBL1, also known as DAN family BMP antagonist, plays a significant role in modulating bone morphogenetic protein (BMP) signaling, which is crucial for various cellular processes such as development, differentiation, and tissue homeostasis. In healthy human cells, NBL1 functions as an antagonist to BMPs, particularly BMP2 and BMP4, by binding to them and inhibiting their signaling pathways. This regulation is essential for maintaining proper cellular signaling outcomes and is involved in processes like limb bud formation, kidney morphogenesis, and left-right axis specification (Nolan2014The; Hung2012DAN).

NBL1 is active in the extracellular space, where it influences tissue development and homeostasis by modulating BMP signaling. It is also involved in wound healing processes, as evidenced by its role in corneal wound healing and scar formation. NBL1 expression increases in activated stromal cells during corneal wound healing, leading to faster wound re-epithelialization and reduced scar formation (Tsai2023NBL1). Additionally, NBL1 interacts with other signaling pathways, such as Wnt and VEGF, which are important for various biological processes (Nolan2014The).

## Clinical Significance
The NBL1 gene, also known as the Neuroblastoma suppressor of tumorigenicity 1, has been implicated in several diseases due to alterations in its expression levels and interactions. Elevated circulating levels of NBL1 are associated with the progression of diabetic kidney disease (DKD) to end-stage kidney disease (ESKD). This association is particularly evident in the apoptosis of podocytes, which are crucial for kidney function, suggesting that NBL1 could be a target for pharmaceutical intervention to slow DKD progression by modulating TGF-β signaling (Kobayashi2022Neuroblastoma). 

In the context of pulmonary arterial hypertension (PAH), NBL1 inhibits the proliferation of human pulmonary artery smooth muscle cells (PASMCs) through the PDGFRβ-p38MAPK signaling pathway. This inhibition is significant in preventing excessive cell proliferation, a key process in PAH pathogenesis (Cui2016Inhibitory). 

NBL1 also plays a role in ovarian function by antagonizing BMP2 and BMP4, which are involved in folliculogenesis. Alterations in NBL1 expression, regulated by gonadotropins and oocyte-derived factors, may impact ovarian follicle maturation and function (Hung2012DAN). These findings highlight the clinical significance of NBL1 in various pathological conditions.

## Interactions
NBL1, also known as neuroblastoma suppressor of tumorigenicity 1, is a member of the DAN family of BMP antagonists. It primarily interacts with bone morphogenetic proteins (BMPs), including BMP2, BMP4, and BMP7, to inhibit their signaling pathways. NBL1 forms noncovalently linked homodimers, which are crucial for its function as a BMP antagonist (Kattamuri2012Members; Hung2012DAN). 

NBL1 competes with BMP ligands for receptor binding, thereby inhibiting BMP signaling. Specific mutations in NBL1, such as S67Y, enhance its inhibitory effect on BMP2 and BMP7, indicating that certain amino acid residues are critical for its interaction with BMP ligands (Nolan2015Structure). 

In the context of small-cell lung cancer (SCLC), NBL1 interacts with neuron-specific enolase (NSE). This interaction attenuates NBL1's inhibitory effect on BMP2, enhancing BMP2 signaling through the BMP2/Smad/ID1 pathway. Overexpression of NBL1 can counteract the effects of NSE, reducing the stem cell-like characteristics of SCLC cells and inhibiting tumor growth (Lu2022Neuronspecific). 

NBL1 does not bind to heparin/heparan oligosaccharides, unlike other DAN family members such as PRDC, due to differences in surface charge distribution (Nolan2015Structure).


## References


[1. (Hung2012DAN) Wei-Ting Hung, Fang-Ju Wu, Chun-Jen Wang, and Ching-Wei Luo. Dan (nbl1) specifically antagonizes bmp2 and bmp4 and modulates the actions of gdf9, bmp2, and bmp4 in the rat ovary1. Biology of Reproduction, May 2012. URL: http://dx.doi.org/10.1095/biolreprod.111.096172, doi:10.1095/biolreprod.111.096172. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1095/biolreprod.111.096172)

[2. (Lu2022Neuronspecific) Lin Lu, Zhiqiang Zha, Peiling Zhang, Peipei Wang, Xia Liu, Xisheng Fang, Chengyin Weng, Baoxiu Li, Haibo Mao, Lina Wang, Mingmei Guan, Yong Wu, Zhixiang Xu, Zhongqiu Liu, and Guolong Liu. Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating nbl1 and activating the bmp2/smad/id1 pathway. Oncogenesis, April 2022. URL: http://dx.doi.org/10.1038/s41389-022-00396-5, doi:10.1038/s41389-022-00396-5. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41389-022-00396-5)

[3. (Nolan2015Structure) Kristof Nolan, Chandramohan Kattamuri, David M. Luedeke, Elizabeth B. Angerman, Scott A. Rankin, Mariana L. Stevens, Aaron M. Zorn, and Thomas B. Thompson. Structure of neuroblastoma suppressor of tumorigenicity 1 (nbl1). Journal of Biological Chemistry, 290(8):4759–4771, February 2015. URL: http://dx.doi.org/10.1074/jbc.m114.628412, doi:10.1074/jbc.m114.628412. This article has 33 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m114.628412)

[4. (Nolan2014The) Kristof Nolan and Thomas B. Thompson. The dan family: modulators of tgf‐β signaling and beyond. Protein Science, 23(8):999–1012, June 2014. URL: http://dx.doi.org/10.1002/pro.2485, doi:10.1002/pro.2485. This article has 84 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/pro.2485)

[5. (Tsai2023NBL1) Chi-Hao Tsai, Emily Liu, Andrew Phan, Krystal Lynn Lu, and Hua Mei. Nbl1 reduces corneal fibrosis and scar formation after wounding. Biomolecules, 13(11):1570, October 2023. URL: http://dx.doi.org/10.3390/biom13111570, doi:10.3390/biom13111570. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom13111570)

[6. (Kattamuri2012Members) Chandramohan Kattamuri, David M. Luedeke, Kristof Nolan, Scott A. Rankin, Kenneth D. Greis, Aaron M. Zorn, and Thomas B. Thompson. Members of the dan family are bmp antagonists that form highly stable noncovalent dimers. Journal of Molecular Biology, 424(5):313–327, December 2012. URL: http://dx.doi.org/10.1016/j.jmb.2012.10.003, doi:10.1016/j.jmb.2012.10.003. This article has 53 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2012.10.003)

[7. (Kobayashi2022Neuroblastoma) Hiroki Kobayashi, Helen C. Looker, Eiichiro Satake, Francesca D’Addio, Jonathan M. Wilson, Pierre Jean Saulnier, Zaipul I. Md Dom, Kristina O’Neil, Katsuhito Ihara, Bozena Krolewski, Hannah S. Badger, Adriana Petrazzuolo, Domenico Corradi, Andrzej Galecki, Parker C. Wilson, Behzad Najafian, Michael Mauer, Monika A. Niewczas, Alessandro Doria, Benjamin D. Humphreys, Kevin L. Duffin, Paolo Fiorina, Robert G. Nelson, and Andrzej S. Krolewski. Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes. Science Translational Medicine, August 2022. URL: http://dx.doi.org/10.1126/scitranslmed.abj2109, doi:10.1126/scitranslmed.abj2109. This article has 18 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/scitranslmed.abj2109)

[8. (Cui2016Inhibitory) Chuanjue Cui, Hongliang Zhang, Lin-Na Guo, Xiaoling Zhang, Liukun Meng, Xiangbin Pan, and Yingjie Wei. Inhibitory effect of nbl1 on pdgf-bb-induced human pasmc proliferation through blockade of pdgfβ-p38mapk pathway. Bioscience Reports, August 2016. URL: http://dx.doi.org/10.1042/bsr20160199, doi:10.1042/bsr20160199. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/bsr20160199)